🇺🇸 FDA
Pipeline program

A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function

323-201-00009

Phase 1 other active

Quick answer

A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function for Tuberculosis is a Phase 1 program (other) at Otsuka Novel Products GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Otsuka Novel Products GmbH
Indication
Tuberculosis
Phase
Phase 1
Modality
other
Status
active

Clinical trials